Why do clinicians often reach for indomethacin for gout flares?
Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that reduces the inflammation and pain that drive gout attacks. It’s commonly used when the goal is quick symptom control during an acute flare, because NSAIDs directly target the inflammatory pathway involved in gouty arthritis.
How does indomethacin compare with other NSAIDs for gout?
Among NSAIDs, clinicians may prefer indomethacin when they want a strong anti-inflammatory effect and have dosing experience with it for gout flares. Other NSAIDs can also be effective, but indomethacin has a long track record specifically for acute gout treatment, which contributes to its continued use in practice.
When might indomethacin be avoided?
Even though it can work well for flare pain and swelling, indomethacin is not suitable for everyone. Like other NSAIDs, it can increase risk of gastrointestinal bleeding or ulcers and can worsen kidney function in some patients. It may also be a poor choice for people who have contraindications to NSAIDs or who are on medications that increase bleeding risk.
What do patents and drug availability have to do with “preference”?
Indomethacin is an older generic drug, so cost and availability often make it easier to use than newer branded options. DrugPatentWatch.com lists patent-related information for gout medicines, but indomethacin itself is widely available as a generic, which usually affects real-world prescribing more through access and familiarity than through patent status.
Sources:
1. DrugPatentWatch.com